Related posts
S&P, Dow hit records, tech soarsThis summary was created by AI, based on 2 opinions in the last 12 months.
Atrion Corp (ATRI-Q) has garnered significant attention from analysts, with two top picks highlighting the company's asset-light business model, which allows for flexible cash allocation. Despite a recent acquisition announcement at $460 per share, which has frustrated some observers who believe the company is worth between $600 to $800 per share, there is recognition of the strategic decision made by aging owners wanting to retire. The company's current assets exceeding total liabilities reinforce its operational stability and potential for growth. Overall, Atrion's outlook remains strong, though the buyout valuation appears contentious among experts, indicating differing perspectives on its true worth.
They make medical supplies, like lens cases for contact lenses. Shares plunged this year due to high interest rates, so their customers didn't buy much from them. But when those customers finish working through their existing inventory, they will order from ATRI again. Trades at only 20x PE, and pay s a 2.5% dividend, which rising 10% annually except this year.
Small caps tend to be less liquid and therefore may have higher betas, although this one is low at 6.1, because it doesn't trade a lot. It makes all kinds of medical devices that none of the big guys want to manufacture. A good entry point would be around $50. This is one you want to hold for the long run.
(A Top Pick Jan 15/16. Up 44.32%.) A tiny little company out of Texas that makes things in the healthcare sector that nobody else wants to create, such as little catheters, IV tubes, cases for contact lenses, etc. His fear is that this company could get bought out because the CEO is getting into his 60s, and succession would be a risk. He wouldn’t buy at this price as it is a little overpriced. Buy on weakness.
(A Top Pick April 4/16. (Actually Jan 15/16.) Up 0.65%.) A little, small medical device company that handles products that larger companies don’t want to be bothered with. It continues to grow very well in the little niches that nobody else wants to do. The dividend has been growing roughly at a 20% clip. Earnings are supposed to be between $15 and $20.
Atrion Corp is a American stock, trading under the symbol ATRI-Q on the NASDAQ (ATRI). It is usually referred to as NASDAQ:ATRI or ATRI-Q
In the last year, 2 stock analysts published opinions about ATRI-Q. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Atrion Corp.
Atrion Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Atrion Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Atrion Corp In the last year. It is a trending stock that is worth watching.
On 2024-08-21, Atrion Corp (ATRI-Q) stock closed at a price of $459.93.
Bought out by another company in August. Asset-light company, where current assets were greater than total liabilities. This type of company is very flexible, allocating cash any way they want.